🇺🇸 FDA
Pipeline program

Azetukalner

XPF-010-B302

Phase 3 small_molecule active

Quick answer

Azetukalner for Bipolar Depression is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Xenon Pharmaceuticals
Indication
Bipolar Depression
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials